Name & Company Information Location Interests Events
409921

Khalil Abdur-Rashid

Harvard University

Muslim Chaplain

Engaging Our Nation and Our World in the Era of Gene Editing
contact_8300

Edward Abrahams, PhD

Personalized Medicine Coalition

President

Washington

United States

BioPharma/Human Health>Diagnostics, BioPharma/Human Health>Therapeutics Biologics, Exhibition Interest>BIO Alliance Pavilion, Management Level>CEO/President/Principal/Founder, Non-Profit>Non-Profit/Patient Advocacy, Program Interest>Personalized Medicine & Diagnostics, Therapeutic/Healthcare Interest>Oncology Cutting Waste in the Link Between Big Pharma and Payers with Precision Medicine
bio2018-mybio-icons-attendees

Dr. Mitch Abrahamsen

Acceligen

Chief Scientific & Commercialization Officer

St. Paul

United States

Acceligen - A Recombinetics Company
356283

Mr. Michael Abrams

Numerof & Associates, Inc.

Managing Partner

Saint Louis

United States

An Investor’s Perspective on Value of New Biotherapeutics
356330

Mr. Michael Adatto

Ferring

AVP, Market Access

Parsippany

United States

Strategies for Selling Value in a Dynamic Environment
414319

Dr. Isaac Adewole

Nigeria

Minister of Health and Oncologist

Market Driven Public-Private Partnerships (PPPs): Building Sustainable Access to Cancer Treatment in Africa
356149

Mr. Amos Adler, MBA,MSc

Memotext Corporation, A4i

CEO

Toronto

Canada

Academic/Non-Profit>Foundation/Patient Advocacy, Academic/Non-Profit>Tech Transfer, Diagnostics/Device/Digital Health>Patient Monitoring Device, Interest Area>Digital Health, Interest Area>Mental Health, Interest Area>Regulatory Innovation, Interest Area>Value, Investor>Angel Or Family Office, Product Focus Zone/Special Pavilion>Patient Advocacy Pavilion, Research Tools/Support>Bioinformatics, Research Tools/Support>Digital Health, Service>CRO & Analytical Labs, Service>Consulting, Session Tracks>Digital Health, Session Tracks>Translational Research Reaching Complex Mental Health Populations with Digital Health Solutions: Serving the Underserved
414306

Prof. Innocent Adoubi

Côte d'Ivoire

National Cancer Director

By Africa, for Africa: Cancer Clinical Trials Driving Access to Medicines & Saving Lives in Africa
bio2018-mybio-icons-attendees

Mukul Agarwal

Revance

Vice President

San Francisco

United States

BioPharma/Human Health>Therapeutics Biologics, Exhibition Interest>Patient Advocacy Pavilion, Management Level>Vice President/General Manager/Partner/Managing Director, Primary Role>Business Development, Program Interest>Clinical Trials, Program Interest>Emerging Opportunities In Global Markets, Program Interest>Personalized Medicine & Diagnostics, Therapeutic/Healthcare Interest>Dermatology, Therapeutic/Healthcare Interest>Neurology, Therapeutic/Healthcare Interest>Pain Management Revance
357520

Marcello Agosti

Takeda Pharmaceuticals

Head of Global Business Development

Deerfield

United States

-
394036

Hon. Jorge Aguado

Argentina

Vice Minister

One Health Day, Scientific American WorldVIEW: Biotechnology’s Promise in a Changing Landscape
423645

Jennifer Ahlstrom

CrowdCare Foundation

President and Co-Founder

-
bio2018-mybio-icons-attendees

Ram Aiyar

Cordiva Therapuetics

EVP Corporate and Business Development

San Francisco

United States

-
355843

Mr. John Alam, ACHA

EIP Pharma

CEO

Cambridge

United States

Exposing Cracks in the Armor of Brain Diseases
bio2018-mybio-icons-attendees

Morgen Alden

LifeSci Advisors

Director of Key Opinion Leader (KOL) Strategy and Management

Board Diversity in Practice: How Great Companies Encourage Gender Diversity at the Top
356179

Ms. Meg Alexander

Syneos Health

Head, Reputation and Risk Management Practice

New York

United States

Communicating Value Through the Eye of the Beholder
388198

Kevin Ali

Merck & Co, Inc.

President, MSD International

Whitehouse Station

United States

Drug Discovery/Research And Development, Pharmaceutical Focus, Vice President/Senior VP/Executive VP Global Leadership Forum: A Fireside Chat with MSD President Kevin Ali on Growth, Opportunities and Challenges (Japan, China and Asia Pacific), Global Leadership Forum: A Fireside Chat with MSD President Kevin Ali on Growth, Opportunities and Challenges (Japan, China and Asia Pacific), Scientific American WorldVIEW: Biotechnology’s Promise in a Changing Landscape
416510

Albert Allen

Eli Lilly and Company

Senior Medical Fellow, Bioethics & Pediatric Capabilities

Academic/Non-Profit>Foundation/Patient Advocacy, Academic/Non-Profit>University (Faculty), Drug>Clinical, Drug>Preclinical, Interest Area>CNS/Neurological, Interest Area>Mental Health, Interest Area>Next Generation Bioetherapeutics, Interest Area>Oncology, Interest Area>Orphan & Rare Diseases, Interest Area>Pain Management, Interest Area>Patient Access & Reimbursement, Interest Area>Personalized Medicine & Diagnostics, Interest Area>Preclinical/Research, Interest Area>Regulatory Innovation, Interest Area>Regulatory Science, Interest Area>Research Tools, Interest Area>Translational Research, Session Tracks>Next Generation Biotherapeutics, Session Tracks>Oncology, Session Tracks>Orphan & Rare Diseases, Session Tracks>Personalized Medicine & Diagnostics, Session Tracks>Regulatory Innovation, Session Tracks>Translational Research Clinical Trial Considerations for Pediatric Oncology and Beyond
401550

Debbie Allen

argenx

Senior Vice President Business Development

Gent

Belgium

Advanced Business Development Course - Day 1 *SOLD OUT*, Advanced Business Development Course - Day 2 *SOLD OUT*, Advanced Business Development Course - Day 3 *SOLD OUT*
399179

Mr. Matthew Allen, CSP

Cabot Corportation

Director of Process Safety (Global)

Billerica

United States

Who’s Nurturing the Next Generation of Innovators?